Impact of target‐mediated drug disposition on hetrombopag pharmacokinetics and pharmacodynamics in Chinese healthy subjects and patients with chronic idiopathic thrombocytopenic purpura-Reference-Cited by-同舟云学术

Impact of target‐mediated drug disposition on hetrombopag pharmacokinetics and pharmacodynamics in Chinese healthy subjects and patients with chronic idiopathic thrombocytopenic purpura

Published:2021-11-13 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Wang Zhenlei¹,Zeng Zhijun¹,Ye Lijun¹²,Zhu Xiaohong¹,Pei Yuwen¹,Wang Yongsheng¹,Zheng Li¹^ORCID

Affiliation:

1. Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug West China Hospital of Sichuan University Chengdu China

2. The Office of Clinical Trial Management/Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine Hangzhou China

Funder

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15130

Reference42 articles.

1. Immune Thrombocytopenic Purpura

2. How I treat idiopathic thrombocytopenic purpura (ITP)

3. The pathogenesis of immune thrombocytopaenic purpura

4. Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management

5. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous analysis of avatrombopag, eltrombopag, and hetrombopag in human plasma by UPLC-MS/MS for therapeutic drug monitoring;Journal of Pharmaceutical and Biomedical Analysis;2023-10